We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Protein Activator Revealed Responsible for Brain Cell Damage in Huntington's Disease

By LabMedica International staff writers
Posted on 29 Jun 2009
Print article
Neuroscientists have discovered why a defective protein accumulates in cells everywhere in the bodies of individuals with Huntington's disease (HD), but only kills cells in the area of the brain that controls movement, causing insignificant damage to tissues elsewhere. The answer lies in one tiny protein called Rhes that is found only in the part of the brain that controls movement. The findings help explain the distinctive pattern of brain damage in HD and its symptoms, as well as offer a new approach for new therapy.

HD itself is caused by a genetic defect that produces a mutant version of the protein huntingtin, which collects in all cells of the body, but only appears to affect the brain. Passed from parent to child through an alteration of a normal gene, HD over time causes irreversible uncontrolled movement, loss of intellectual function, emotional disturbances, and death.

"It's always been a mystery why, if the protein made by the HD gene is seen in all cells of the body, only the brain, and only a particular part of the brain, the corpus striatum, deteriorates,” said Solomon H. Snyder, M.D., a professor of neuroscience at Johns Hopkins University (Baltimore, MD, USA). "By finding the basic culprit, the potential is there to develop drugs that target it and either prevent symptoms or slow them down.”

Curious about the huntingtin protein's striatal-specific effect, Dr. Snyder's research team, led by Srinivasa Subramaniam, Ph.D., a postdoctoral fellow, looked for proteins that interacted locally, specifically, and only with huntingtin in the corpus striatum, guessing that the molecular answer to the mystery most likely would be found there.

The protein Rhes caught the investigators attention because they already were studying a related protein for other reasons. Rhes was known to be found almost exclusively in the corpus striatum. Conducting tests using human and mouse cells, they found that Rhes interacted with both healthy and mutant versions of huntingtin protein, but bound much more strongly to mutant huntingtin (mHtt). "Touching or binding is one matter, but death is altogether another,” said Dr. Snyder, so the next step was to see whether and how Rhes plus mHtt could kill brain cells in the corpus striatum.

Utilizing human embryonic cells and brain cells gathered from mice the researchers added different combinations of normal and mutant huntingtin and Rhes, and examined the cells over the next week to see if any cells died. While each protein alone did not alter the number of cells in the dishes, when both mHtt and Rhes were present in the same cells, half the cells died within 48 hours. "Here's the Rhes protein, we've known about it for years, nobody ever really knew what it did in the brain or anywhere else,” said Dr. Snyder. "And it turns out, it looks like the key to Huntington's disease.”

The researchers then went on to confront another mystery surrounding the disease, the solution to this one adding further evidence for the role Rhes plays in HD. "We've known for a long time that abnormal huntingtin proteins aggregate and form clumps in all cells of the body, but the corpus striatum of HD patients seems to have fewer of these clumps than other brain regions or the rest of the body,” said Dr. Subramaniam in describing the mystery. "This has led to much controversy: are the clumps toxic, or is it the lack of clumps that's toxic to these brain cells?”

In the study, adding Rhes to cells with abnormal huntingtin led to fewer clumps, but the cells died. The results, according to Dr. Subramaniam, suggest that Rhes might be responsible for unclumping mutant huntingtin protein and this somehow kills cells. "Since Rhes is highly found in the corpus striatum, clumping somehow protects cells in other tissues of the body from dying,” he noted.

The researchers are now exploring whether removing Rhes from mice with Huntington's disease can suppress or stop brain cells from dying. "Now that we've uncovered the role of Rhes, it's possible that drugs can be designed that specifically target Rhes to treat or even prevent the disease,” stated Dr. Snyder.

The study was funded by a U.S. Public Health Service grant and Research Scientist Awards, and the findings were published in the June 5, 2009, issue of Science.

Related Links:

Johns Hopkins University


Gold Member
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Automated Blood Typing System
IH-500 NEXT
New
Thyroid ELISA Kit
AESKULISA a-TPO
New
Urine Collection Container
Urine Monovette

Print article

Channels

Clinical Chemistry

view channel
Image: The new saliva-based test for heart failure measures two biomarkers in about 15 minutes (Photo courtesy of Trey Pittman)

POC Saliva Testing Device Predicts Heart Failure in 15 Minutes

Heart failure is a serious condition where the heart muscle is unable to pump sufficient oxygen-rich blood throughout the body. It ranks as a major cause of death globally and is particularly fatal for... Read more

Hematology

view channel
Image: The smartphone technology measures blood hemoglobin levels from a digital photo of the inner eyelid (Photo courtesy of Purdue University)

First-Of-Its-Kind Smartphone Technology Noninvasively Measures Blood Hemoglobin Levels at POC

Blood hemoglobin tests are among the most frequently conducted blood tests, as hemoglobin levels can provide vital insights into various health conditions. However, traditional tests are often underutilized... Read more

Immunology

view channel
Image: Under a microscope, DNA repair is visible as bright green spots (“foci”) in the blue-stained cell DNA. Orange highlights actively growing cancer cells (Photo courtesy of WEHI)

Simple Blood Test Could Detect Drug Resistance in Ovarian Cancer Patients

Every year, hundreds of thousands of women across the world are diagnosed with ovarian and breast cancer. PARP inhibitors (PARPi) therapy has been a major advancement in treating these cancers, particularly... Read more

Microbiology

view channel
Image: HNL Dimer can be a novel and potentially useful clinical tool in antibiotic stewardship in sepsis (Photo courtesy of Shutterstock)

Unique Blood Biomarker Shown to Effectively Monitor Sepsis Treatment

Sepsis remains a growing problem across the world, linked to high rates of mortality and morbidity. Timely and accurate diagnosis, along with effective supportive therapy, is essential in reducing sepsis-related... Read more

Pathology

view channel
Image: The AI program analyzes a microscopy image from a tumor biopsy and determines what genes are likely turned on and off in the cells it contains (Photo courtesy of Olivier Gevaert/Stanford Medicine)

AI Tool ‘Sees’ Cancer Gene Signatures in Biopsy Images

To assess the type and severity of cancer, pathologists typically examine thin slices of a tumor biopsy under a microscope. However, to understand the genomic alterations driving the tumor's growth, scientists... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.